Robert F. Kennedy Jr., if confirmed as HHS secretary, could help food-as-medicine startups expand with wider government health plan coverage.

However, #EliLilly did the unimaginable with a $500M investment into a new fund called 'Biotech Ecosystem Venture Fund' to be co-managed with Andreessen Horowitz. This is pushing the boundaries ...

STAT+: Spurred by AI’s possibilities, Eli Lilly and Andreessen Horowitz partner on $500M venture fund https://lnkd.in/gd9PE_qE In an apparently unprecedented move, Eli Lilly is partnering with ...

Eli Lilly's small pop was due to the latest developments in the lab reported by Novo Nordisk (NYSE: NVO), which, like the U.S. company, is doing brisk business with a weight loss drug: Wegovy ...

Investing.com -- Shares of pharmaceutical giant Eli Lilly (NYSE:LLY) edged down 1.2% in premarket trading following announcements from competitor Novo Nordisk (NYSE:NVO) regarding their new weight ...

Venture capital firm Andreessen Horowitz will be pulling back its operations in the UK in response to US President Donald Trump’s “strong policy momentum” on crypto. In a Jan. 24 X post ...

Eli Lilly (NYSE: LLY) has become a beast in healthcare. The excitement surrounding its GLP-1 drugs, Mounjaro and Zepbound, has helped boost its market capitalization to around $650 billion.

Andreessen Horowitz will close down its UK office a little over a year after it opened, as it plans to focus on its home market under the crypto-friendly stance of US President Donald Trump. The ...

In the latest trading session, Eli Lilly (LLY) closed at $753.98, marking a +1.57% move from the previous day. This move outpaced the S&P 500's daily gain of 0.61%. Meanwhile, the Dow gained 0.3% ...

Despite being in the age of tech-stock blue-sky investing, many investors still adopt a more traditional strategy; buying shares in profitable companies like Eli Lilly (NYSE:LLY). While profit isn ...